MRNA vs VIAV · rev $145.0M vs rev $1.52B
Moderna Inc (MRNA) versus Viavi Solutions Inc (VIAV) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Viavi Solutions Inc (VIAV) is a communication equipment company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported VIAV revenue for 2026-06-27 was $1.52B. Net income was -$30.4M. Revenue was up 40.0% from 2025-06-28 to 2026-06-27. VIAV currently screens at market cap $12.25B.
MRNA currently screens at market cap $24.52B. VIAV currently screens at market cap $12.25B.
Not investment advice. Open the MRNA and VIAV stock pages for the full models.
Not investment advice.